Global mRNA Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

Global mRNA Transcriptome Sequencing Market Growth (Status and Outlook) 2023-2029

The global mRNA Transcriptome Sequencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for mRNA Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for mRNA Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for mRNA Transcriptome Sequencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key mRNA Transcriptome Sequencing players cover Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.

Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated—giving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.

LPI (LP Information)' newest research report, the “mRNA Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world mRNA Transcriptome Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected mRNA Transcriptome Sequencing sales for 2023 through 2029. With mRNA Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Transcriptome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global mRNA Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on mRNA Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Transcriptome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Transcriptome Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Transcriptome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Transcriptome Sequencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Next Generation Sequencing
Single Molecule Sequencing
Others

Segmentation by application
Biomedical Field
Non-medical Field

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.